Zachariah Mc Iver is Chief Medical Officer of Janux Therapeutics, Inc.. Currently has a direct ownership of 23,286 shares of JANX, which is worth approximately $681,814. The most recent transaction as insider was on Jan 02, 2026, when has been sold 2,714 shares (Common Stock) at a price of $13.73 per share, resulting in proceeds of $37,263. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.3K
10.44% 3M change
10.44% 12M change
Total Value Held $681,814

Zachariah McIver Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2026
SELL
Open market or private sale
$37,263 $13.73 p/Share
2,714 Reduced 10.44%
23,286 Common Stock
Jan 02 2026
BUY
Grant, award, or other acquisition
-
29,000 Added 35.68%
52,286 Common Stock
Jan 02 2025
BUY
Grant, award, or other acquisition
-
26,000 Added 50.0%
26,000 Common Stock
ZM

Zachariah Mc Iver

Chief Medical Officer
San Diego, CA

Track Institutional and Insider Activities on JANX

Follow Janux Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JANX shares.

Notify only if

Insider Trading

Get notified when an Janux Therapeutics, Inc. insider buys or sells JANX shares.

Notify only if

News

Receive news related to Janux Therapeutics, Inc.

Track Activities on JANX